HCPCS drug code · CMS crosswalk
Tobramycin Sulfate J-Code / HCPCS Code
In short
Tobramycin Sulfate is billed under HCPCS J3260 — Injection, tobramycin sulfate, up to 80 mg. One billing unit is 80 mg. CMS's crosswalk lists 18 Tobramycin Sulfate NDCs under this code.
Reference
- J3260
- Injection, tobramycin sulfate, up to 80 mgBilling unit: 80 mg
- Labelers
- Baxter Healthcare Corporation; Eugia US LLC; Fosun Pharma USA Inc.; FreseniUS Kabi USA, LLC; Mylan Institutional LLC; Northstar RxLLC; Pfizer Inc; Slate Run Pharmaceuticalsand 2 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Tobramycin Sulfate units and claim line
Enter the dose given to get the J3260 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Tobramycin Sulfate NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00409-3578-01 | J3260 | Pfizer Inc | 25 × 2 | 25 |
| 36000-0242-01 | J3260 | Baxter Healthcare Corporation | 1 | 15 |
| 36000-0244-25 | J3260 | Baxter Healthcare Corporation | 25 × 2 | 25 |
| 39822-0412-01 | J3260 | XGen Pharmaceuticals DJB, Inc. | 1 | 15 |
| 39822-0412-06 | J3260 | XGen Pharmaceuticals DJB, Inc. | 6 × 1 | 90 |
| 55150-0470-06 | J3260 | Eugia US LLC | 6 × 1 | 90 |
| 63323-0303-51 | J3260 | FreseniUS Kabi USA, LLC | 6 × 1 | 90 |
| 63323-0303-55 | J3260 | FreseniUS Kabi USA, LLC | 6 × 1 | 90 |
| 63323-0305-02 | J3260 | FreseniUS Kabi USA, LLC | 25 × 2 | 7 |
| 63323-0306-02 | J3260 | FreseniUS Kabi USA, LLC | 25 × 2 | 25 |
| 63323-0306-30 | J3260 | FreseniUS Kabi USA, LLC | 10 × 30 | 150 |
| 67457-0428-30 | J3260 | Mylan Institutional LLC | 10 × 30 | 150 |
| 67457-0473-22 | J3260 | Mylan Institutional LLC | 25 × 2 | 25 |
| 70436-0110-56 | J3260 | Slate Run Pharmaceuticals | 6 × 1 | 90 |
| 70436-0110-80 | J3260 | Slate Run Pharmaceuticals | 1 | 15 |
| 70700-0173-86 | J3260 | Xiromed, LLC | 6 × 1 | 90 |
| 72266-0163-06 | J3260 | Fosun Pharma USA Inc. | 6 × 1 | 90 |
| 72603-0160-06 | J3260 | Northstar RxLLC | 6 × 1 | 90 |
Tobramycin Sulfate: common questions
- What is the J-code for Tobramycin Sulfate?
- Tobramycin Sulfate is billed under HCPCS J3260 — Injection, tobramycin sulfate, up to 80 mg. One billing unit is 80 mg. CMS's crosswalk lists 18 Tobramycin Sulfate NDCs under this code.
- How many J3260 billing units are in a package of Tobramycin Sulfate?
- CMS lists 7 to 150 billing units per package, depending on the NDC, where one unit is 80 mg. Units to report are based on the dose given, not the package.
- Is J3260 a CPT code?
- No. J3260 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.